HomeCompareASFX vs SBUX

ASFX vs SBUX: Dividend Comparison 2026

ASFX yields 5000000.00% · SBUX yields 2.84%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ASFX wins by $4.651129742658086e+43M in total portfolio value
10 years
ASFX
ASFX
● Live price
5000000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.651129742658086e+43M
Annual income
$46,509,467,603,334,410,000,000,000,000,000,000,000,000,000,000,000.00
Full ASFX calculator →
SBUX
SBUX
● Live price
2.84%
Share price
$86.72
Annual div
$2.46
5Y div CAGR
48.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$167.0K
Annual income
$71,136.45
Full SBUX calculator →

Portfolio growth — ASFX vs SBUX

📍 ASFX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodASFXSBUX
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ASFX + SBUX cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ASFX pays
SBUX pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ASFX
Annual income on $10K today (after 15% tax)
$425,000,000.00/yr
After 10yr DRIP, annual income (after tax)
$39,533,047,462,834,250,000,000,000,000,000,000,000,000,000,000,000.00/yr
SBUX
Annual income on $10K today (after 15% tax)
$241.12/yr
After 10yr DRIP, annual income (after tax)
$60,465.98/yr
At 15% tax rate, ASFX beats the other by $39,533,047,462,834,250,000,000,000,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ASFX + SBUX for your $10,000?

ASFX: 50%SBUX: 50%
100% SBUX50/50100% ASFX
Portfolio after 10yr
$2.325564871329043e+43M
Annual income
$23,254,733,801,667,206,000,000,000,000,000,000,000,000,000,000,000.00/yr
Blended yield
100.00%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on SBUX right now

ASFX
No analyst data
SBUX
Analyst Ratings
28
Buy
27
Hold
3
Sell
Consensus: Buy
Price Target
$104.00
+19.9% upside vs current
Range: $90.00 — $120.00
Altman Z
2.6
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ASFX buys
0
SBUX buys
0
No recent congressional trades found for ASFX or SBUX in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricASFXSBUX
Forward yield5000000.00%2.84%
Annual dividend / share$2.00$2.46
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%48.3%
Portfolio after 10y$4.651129742658086e+43M$167.0K
Annual income after 10y$46,509,467,603,334,410,000,000,000,000,000,000,000,000,000,000,000.00$71,136.45
Total dividends collected$4.651117771440442e+43M$136.4K
Payment frequencyquarterlyquarterly
SectorStockConsumer Discretionary

Year-by-year: ASFX vs SBUX ($10,000, DRIP)

YearASFX PortfolioASFX Income/yrSBUX PortfolioSBUX Income/yrGap
1← crossover$500,010,700$500,000,000.00$11,121$420.68+$500.00MASFX
2$23,365,520,992,757$23,364,985,981,308.41$12,548$648.40+$23365520.98MASFX
3$1,020,442,548,175,215,100$1,020,417,547,067,752,800.00$14,440$1,013.98+$1020442548175.20MASFX
4$41,650,346,151,752,480,000,000$41,649,254,278,225,940,000,000.00$17,068$1,617.30+$41650346151752480.00MASFX
5$1,588,787,048,835,084,000,000,000,000$1,588,742,482,964,701,800,000,000,000.00$20,912$2,649.52+$1.588787048835084e+21MASFX
6$56,640,860,400,245,200,000,000,000,000,000$56,639,160,398,102,940,000,000,000,000,000.00$26,875$4,499.29+$5.66408604002452e+25MASFX
7$1,887,170,449,619,629,000,000,000,000,000,000,000$1,887,109,843,899,000,500,000,000,000,000,000,000.00$36,771$8,014.12+$1.887170449619629e+30MASFX
8$58,763,764,792,023,670,000,000,000,000,000,000,000,000$58,761,745,519,642,570,000,000,000,000,000,000,000,000.00$54,542$15,197.11+$5.876376479202367e+34MASFX
9$1,710,115,183,602,138,000,000,000,000,000,000,000,000,000,000$1,710,052,306,373,811,000,000,000,000,000,000,000,000,000,000.00$89,602$31,242.49+$1.710115183602138e+39MASFX
10$46,511,297,426,580,864,000,000,000,000,000,000,000,000,000,000,000$46,509,467,603,334,410,000,000,000,000,000,000,000,000,000,000,000.00$167,011$71,136.45+$4.651129742658086e+43MASFX

ASFX vs SBUX: Complete Analysis 2026

ASFXStock

American Scientific Resources, Incorporated develops, manufactures, assembles, markets, and distributes medical products and devices for children and adults. It offers Thermofocus 5-in-1, a non-contact clinical thermometer; VeraTemp and VeraTemp+ non-contact thermometers; Scald Safe Water temperature disc, a warning disc that helps to ensure that a baby's bath water is at an appropriate temperature; and WhistleWatch, a flow monitoring device that allows parents to monitor their child's respiratory problems. The company also provides Kidz-Med portable ultrasonic nebulizer, which is used to treat asthma, bronchitis, allergies, and sinusitis; Kidz-Med Medicine Dispenser that consists of an orthodontic nipple attached to a medication chamber; and Kidz-Med Mommy Recorder, a voice-recording device, which allows a mother to record a message designed to calm baby when he or she is upset. In addition, it offers Bip DVDs, a video series to help children understand life events; Mebby product line that includes breast pumps, bisphenol A free baby bottles, digital scales, humidifiers, pacifiers, & sterilizers; and Wee Target, a toilet training device for young boys. Further, the company provides Disintegrator, a home needle and lancet destruction device, which enables patients who give themselves injections, including those suffering from multiple sclerosis or diabetes to properly and safely dispose of needles at home. American Scientific Resources distributes its products primarily through retail drug and grocery chains, and medical suppliers, as well as through its Web site and other on-line sites. The company is based in Weston, Florida. On February 27, 2012, an involuntary petition for liquidation under Chapter 7 was filed against American Scientific Resources, Incorporated in the US Bankruptcy Court for the Southern District of Florida. On March 28, 2012, the involuntary petition was approved by the Court. American Scientific Resources, Inc. is in liquidation.

Full ASFX Calculator →

SBUXConsumer Discretionary

Starbucks Corporation, together with its subsidiaries, operates as a roaster, marketer, and retailer of specialty coffee worldwide. The company operates through three segments: North America, International, and Channel Development. Its stores offer coffee and tea beverages, roasted whole beans and ground coffees, single serve products, and ready-to-drink beverages; and various food products, such as pastries, breakfast sandwiches, and lunch items. The company also licenses its trademarks through licensed stores, and grocery and foodservice accounts. The company offers its products under the Starbucks, Teavana, Seattle's Best Coffee, Evolution Fresh, Ethos, Starbucks Reserve, and Princi brands. As of October 3, 2021, it operated 16,826 company-operated and licensed stores in North America; and 17,007 company-operated and licensed stores internationally. The company was founded in 1971 and is based in Seattle, Washington.

Full SBUX Calculator →
📬

Get this ASFX vs SBUX comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ASFX vs SCHDASFX vs JEPIASFX vs OASFX vs KOASFX vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.